G

GlyProVac LLC

7 employees

GlyProVac is pursuing the development of a glycoprotein based vaccine against Enterotoxigenic Escherichia coli (ETEC).

Basic info

biotechnology research

Bacterial Pathogens

Biopharma

Molecular Biology

Mass Spectrometry

Microbiology

2018